Related Experiment Video
Updated: Jun 12, 2026

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
Published on: March 22, 2011
A third-generation herpesvirus is effective against gastroesophageal cancer
Joyce Wong1, Kaitlyn Kelly, Arjun Mittra
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Background:
Gastroesophageal cancer remains a leading cause of cancer deaths and is uniformly fatal in patients presenting with metastases and recurrence. This study sets out to determine the effect of a third-generation, replication-competent, oncolytic herpes simplex type 1 virus containing transgenes encoding for a fusogenic membrane glycoprotein and Fcy::Fur, against gastroesophageal cancer.
Methods:
The cytotoxic effect of the virus was tested on human gastroesophageal cancer cell lines OCUM-2MD3, MKN-45, AGS, MKN-1, MKN-74, and BE-3 at sequential multiplicities of infection (MOI). Cytotoxicity was measured using a lactate dehydrogenase assay. Viral replication was tested by serially diluting supernatants from viral infections and titering on VERO cells via standard plaque assay. Correlations of cytotoxicity and viral replication were also investigated.
Results:
All cell lines were susceptible to viral infection and demonstrated a dose-dependent effect, with greater and faster cytotoxicity at higher MOIs. Viral replication was supported in the cell lines tested, with peak titers by d 5, some supporting as high as >40,000× amplification. Cell lines with longer doubling times (>30 h) also achieved higher viral titers at a MOI of 0.1. Cell lines with shorter doubling times achieved 50% cell kill in fewer days, with an average of 2.3 d for cell lines with doubling times under 30 h compared with 4.4 d for cell lines with doubling times over 30 h.
Conclusion:
These results suggest that this third-generation oncolytic herpesvirus can effectively infect and lyse gastroesophageal cancer cells and may provide a novel therapy against gastroesophageal cancer.
Insights
A novel oncolytic herpesvirus effectively infected and killed gastroesophageal cancer cells in vitro. This replication-competent virus shows promise as a new therapeutic strategy for this deadly cancer.
Area of Science:
- Oncolytic virotherapy
- Cancer biology
- Virology
Background:
- Gastroesophageal cancer is a leading cause of cancer mortality, often fatal with metastasis or recurrence.
- Current treatment options for advanced gastroesophageal cancer are limited.
- Novel therapeutic strategies are urgently needed.
Purpose of the Study:
- To evaluate the efficacy of a third-generation, replication-competent oncolytic herpes simplex type 1 virus against gastroesophageal cancer.
- To assess the virus's cytotoxic effects and replication capabilities in human gastroesophageal cancer cell lines.
Main Methods:
- Tested the cytotoxic effect of the oncolytic virus on six human gastroesophageal cancer cell lines at various multiplicities of infection (MOI).
- Measured cytotoxicity using a lactate dehydrogenase assay.
- Assessed viral replication through plaque assays and correlated cytotoxicity with viral replication.
Main Results:
- All tested gastroesophageal cancer cell lines were susceptible to viral infection, showing dose-dependent cytotoxicity.
- Higher MOIs resulted in faster and greater cancer cell death.
- The virus replicated effectively in the cell lines, with some supporting over 40,000x amplification.
- Cell lines with shorter doubling times exhibited faster cell kill (average 2.3 days) compared to those with longer doubling times (average 4.4 days).
Conclusions:
- The third-generation oncolytic herpesvirus demonstrates significant potential for treating gastroesophageal cancer.
- The virus effectively infects and lyses gastroesophageal cancer cells.
- This oncolytic herpesvirus may represent a novel therapeutic approach for gastroesophageal cancer.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Genital Herpes
Herpes
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers

